Revolution Medicines price target raised to 56 from 44 at H.C. Wainwright - TipRanks

RVMD Stock  USD 57.85  0.73  1.25%   
About 62% of Revolution Medicines' investor base is looking to short. The analysis of the overall investor sentiment regarding Revolution Medicines suggests that many traders are alarmed. The current market sentiment, together with Revolution Medicines' historical and current headlines, can help investors time the market. In addition, many technical investors use Revolution Medicines stock news signals to limit their universe of possible portfolio assets.
  
Revolution Medicines price target raised to 56 from 44 at H.C. Wainwright TipRanks

Read at news.google.com
Google News at Macroaxis
  

Revolution Medicines Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Revolution Medicines can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Revolution Medicines Fundamental Analysis

We analyze Revolution Medicines' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Revolution Medicines using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Revolution Medicines based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Return On Asset

Return On Asset Comparative Analysis

Revolution Medicines is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Revolution Medicines Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Revolution Medicines stock to make a market-neutral strategy. Peer analysis of Revolution Medicines could also be used in its relative valuation, which is a method of valuing Revolution Medicines by comparing valuation metrics with similar companies.

Peers

Revolution Medicines Related Equities

PASGPassage Bio   68.66   
0%
100.0%
GLUEMonte Rosa   13.72   
0%
19.0%
SANASana Biotechnology   9.02   
0%
13.0%
CCCCC4 Therapeutics   8.59   
0%
12.0%
NRIXNurix Therapeutics   4.15   
0%
6.0%
BDTXBlack Diamond   3.11   
0%
4.0%
STOKStoke Therapeutics   1.68   
0%
2.0%
BPMCBlueprint Medicines   1.35   
0%
1.0%
AGIOAgios Pharm   1.24   
0%
1.0%
KYMRKymera Therapeutics   0.02   
1.0%
0%
AKROAkero Therapeutics   0.22   
1.0%
0%
RNAAvidity Biosciences   0.69   
1.0%
0%
PTGXProtagonist Therapeutics   2.56   
3.0%
0%

Complementary Tools for Revolution Stock analysis

When running Revolution Medicines' price analysis, check to measure Revolution Medicines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines is operating at the current time. Most of Revolution Medicines' value examination focuses on studying past and present price action to predict the probability of Revolution Medicines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines' price. Additionally, you may evaluate how the addition of Revolution Medicines to your portfolios can decrease your overall portfolio volatility.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Money Managers
Screen money managers from public funds and ETFs managed around the world
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets